Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Thyroid Neoplasms 12Thyroid Cancer, Papillary 5Adenocarcinoma, Follicular 5Differentiated Thyroid Cancer 4Recombinant Human Thyroid Stimulating Hormone 1Neoplasm Metastasis 1Metastatic Radioactive Iodine Refractory Thyroid Cancer Patients With RAS or BRAF Mutation 1Low Risk Differentiated Thyroid Cancer 1Hypothyroidism 1Heterotaxy Syndrome 1Head and Neck Neoplasms 1DTC - Differentiated Thyroid Cancer 1

Interventions

Thyroxine 7Triiodothyronine 3Water 1Thyrotropin-Releasing Hormone 1Thyrotropin Alfa 1Thyroid (USP) 1Therapeutics 1Tea 1Remote Consultation 1Radiotherapy, Intensity-Modulated 1Milk 1Lenalidomide 1Glucose 1Coffee 1Clinical Protocols 1Antithyroid Agents 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hypothyroidism × Thyrotropin Alfa × Head & Neck × Clear all
NCT00001730 2008-03-04

Study of Radioiodine (131-I) Uptake Following Administration of Thyrogen and Hypothyroid States During Thyroid Hormone Withdrawal.

National Institutes of Health Clinical Center (CC)

Phase 4 Completed
20 enrolled
Head & Neck

Hypothyroidism, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡